Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.

Shanghai Soho-Yiming Pharmaceuticals Co., Ltd. (SHYM-Pharma), formerly Shanghai Zillion Pharmaceuticals Co., Ltd., is a high-tech enterprise in Shanghai dedicated to R&D, manufacturing and marketing in the peptide synthesis field, supported by a well-equipped laboratory and an experienced team. Founded in 2001, it has grown into a leading Chinese peptide synthesis manufacturer, able to supply a wide range of peptides from milligram to kilogram scale at good quality and competitive pricing for commercial use. Its facilities apply solid-phase synthesis technology alongside advanced software and equipment - including peptide synthesizers, HPLC for separation and purification, mass spectrometry and freeze-dryers - enabling the design and synthesis of peptides at various scales to fit different needs. Under strict GMP standards, SHYM-Pharma manufactures high-quality peptides including Somatostatin, Octreotide, Thymopentin, Salmon Calcitonin, Oxytocin, Leuprorelin, Triptorelin, Desmopressin, Thymosin α1, Terlipressin, ACTH, Gonadorelin Acetate, GHRP-2, GHRP-6, Exenatide, Alarelin, Atosiban, Argireline, Bivalirudin, Deslorelin, Eptifibatide, Glucagon, Melanotan II, Teriparatide, Sermorelin, Nafarelin, Lyspressin, Ornipressin, Pramlintide, Cetrorelix, Bremelanotide (PT141), Buserelin and others. Drawing on its extensive experience and skilled technical team, the company also offers custom peptide synthesis for both research and bulk trial purposes, including high-grade purification services for custom-synthesized peptides.